G S M Sundaram

Title: G S M Sundaram: Innovator in Biomedical Imaging

Introduction

G S M Sundaram is a notable inventor based in Saint Louis, MO (US). He has made significant contributions to the field of biomedical imaging, particularly in the development of probes for Alzheimer's disease diagnosis and monitoring.

Latest Patents

Sundaram holds a patent for "Heterocyclic molecules for biomedical imaging and therapeutic applications." This patent describes probes that target both diffuse and fibrillar forms of amyloid beta (Aβ). These innovative probes demonstrate high initial brain penetration and facilitate clearance from non-targeted regions. They can be utilized to quantitatively image amyloid for monitoring the efficacy of Aβ-modifying therapeutics and assist in the premortem diagnosis of Alzheimer's disease (AD). The disclosed probes can bind Aβ aggregates of preformed Aβ fibrils in vitro and can image fibrillar and diffuse plaques ex vivo in brain sections. Furthermore, these probes can determine Aβ burden in the early stages of AD and are capable of multimodality imaging of Aβ. For instance, F-AI-187 (1 µM) can detect Aβ plaques in brain sections of APP/PS1 mice, while F-AI-187 (10 µM) can detect Aβ plaques in the frontal lobe of a brain section from a patient with confirmed AD. Some of these probes are also suitable for fluorescence imaging of plaques.

Career Highlights

Sundaram is affiliated with Washington University, where he continues to advance research in biomedical imaging. His work has garnered attention for its potential impact on Alzheimer's disease diagnosis and treatment.

Collaborations

Sundaram collaborates with notable colleagues, including Jothilingam Sivapackiam and Vijay K Sharma, who contribute to his research endeavors.

Conclusion

G S M Sundaram's innovative work in developing probes for Alzheimer's disease imaging represents a significant advancement in biomedical research. His contributions are poised to enhance the understanding and treatment of this challenging condition.